Lulizumab

Tax included
Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling.
MedChemExpress 
HY-P99302

Data sheet

Size
Multiple sizes
Reactivity
CD28
Application
COVID-19-immunoregulation
CAS
2235419-62-0